These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 18083572

  • 21. Immunotherapy of established (pre)malignant disease by synthetic long peptide vaccines.
    Melief CJ, van der Burg SH.
    Nat Rev Cancer; 2008 May; 8(5):351-60. PubMed ID: 18418403
    [Abstract] [Full Text] [Related]

  • 22. Should dendritic cell-based tumor vaccination be incorporated into standard therapy for newly diagnosed glioblastoma patients?
    Van Gool S, De Vleeschouwer S.
    Expert Rev Neurother; 2012 Oct; 12(10):1173-6. PubMed ID: 23082731
    [No Abstract] [Full Text] [Related]

  • 23. Autologous soluble tumor-associated antigens prevent the toxic side effects of cancer chemotherapy and inhibit the progress of tumorigenesis: case report.
    Ben-Hur H, Zusman R, Zusman I.
    Oncol Rep; 2003 Oct; 10(6):2059-61. PubMed ID: 14534743
    [Abstract] [Full Text] [Related]

  • 24. [Peptide vaccination therapy for malignant glioma].
    Yamanaka R, Itoh K.
    Brain Nerve; 2007 Mar; 59(3):251-61. PubMed ID: 17370651
    [Abstract] [Full Text] [Related]

  • 25. Immunotherapy of hematological malignancies using dendritic cells.
    Van de Velde AL, Berneman ZN, Van Tendeloo VF.
    Bull Cancer; 2008 Mar; 95(3):320-6. PubMed ID: 18390412
    [Abstract] [Full Text] [Related]

  • 26. Local administration of PF-3512676 CpG-B instigates tumor-specific CD8+ T-cell reactivity in melanoma patients.
    Molenkamp BG, Sluijter BJ, van Leeuwen PA, Santegoets SJ, Meijer S, Wijnands PG, Haanen JB, van den Eertwegh AJ, Scheper RJ, de Gruijl TD.
    Clin Cancer Res; 2008 Jul 15; 14(14):4532-42. PubMed ID: 18628468
    [Abstract] [Full Text] [Related]

  • 27. [Pilot trial of vaccines based on autologous dendritic cells loaded in vitro with tumor antigens in the treatment of cancer of the urinary bladder].
    Shoua AB, Sergienco NF, Sitnikov NV, Chkadua GZ.
    Urologiia; 2008 Jul 15; (5):54-7. PubMed ID: 19069498
    [Abstract] [Full Text] [Related]

  • 28. Phase II randomized controlled trial of an epidermal growth factor vaccine in advanced non-small-cell lung cancer.
    Neninger Vinageras E, de la Torre A, Osorio Rodríguez M, Catalá Ferrer M, Bravo I, Mendoza del Pino M, Abreu Abreu D, Acosta Brooks S, Rives R, del Castillo Carrillo C, González Dueñas M, Viada C, García Verdecia B, Crombet Ramos T, González Marinello G, Lage Dávila A.
    J Clin Oncol; 2008 Mar 20; 26(9):1452-8. PubMed ID: 18349395
    [Abstract] [Full Text] [Related]

  • 29. Active immunotherapy of multiple myeloma.
    Houet L, Veelken H.
    Eur J Cancer; 2006 Jul 20; 42(11):1653-60. PubMed ID: 16797966
    [Abstract] [Full Text] [Related]

  • 30. Surgery and adjuvant dendritic cell-based tumour vaccination for patients with relapsed malignant glioma, a feasibility study.
    Rutkowski S, De Vleeschouwer S, Kaempgen E, Wolff JE, Kühl J, Demaerel P, Warmuth-Metz M, Flamen P, Van Calenbergh F, Plets C, Sörensen N, Opitz A, Van Gool SW.
    Br J Cancer; 2004 Nov 01; 91(9):1656-62. PubMed ID: 15477864
    [Abstract] [Full Text] [Related]

  • 31. A modified epitope identified for generation and monitoring of PSA-specific T cells in patients on early phases of PSA-based immunotherapeutic protocols.
    Lundberg K, Roos AK, Pavlenko M, Leder C, Wehrum D, Guevara-Patiño J, Andersen RS, Pisa P.
    Vaccine; 2009 Mar 04; 27(10):1557-65. PubMed ID: 19171173
    [Abstract] [Full Text] [Related]

  • 32. Vaccine therapy in patients with renal cell carcinoma.
    Van Poppel H, Joniau S, Van Gool SW.
    Eur Urol; 2009 Jun 04; 55(6):1333-42. PubMed ID: 19201522
    [Abstract] [Full Text] [Related]

  • 33. The Preuss Foundation Seminar on vaccine therapy for malignant primary brain tumors. February 15-17, 1998, La Jolla, Calif.
    Sampson JH.
    Neuro Oncol; 1999 Jan 04; 1(1):33-42. PubMed ID: 11550300
    [No Abstract] [Full Text] [Related]

  • 34. Dendritic cell vaccination induces tumor epitope-specific Th1 immune response in medullary thyroid carcinoma.
    Papewalis C, Wuttke M, Jacobs B, Domberg J, Willenberg H, Baehring T, Cupisti K, Raffel A, Chao L, Fenk R, Seissler J, Scherbaum WA, Schott M.
    Horm Metab Res; 2008 Feb 04; 40(2):108-16. PubMed ID: 18283628
    [Abstract] [Full Text] [Related]

  • 35. Immunoregulatory T cells in the peripheral blood of melanoma patients treated with melanoma antigen-pulsed mature monocyte-derived dendritic cell vaccination.
    Nakai N, Katoh N, Kitagawa T, Ueda E, Takenaka H, Kishimoto S.
    J Dermatol Sci; 2009 Apr 04; 54(1):31-7. PubMed ID: 19157789
    [Abstract] [Full Text] [Related]

  • 36. Cancer vaccines for established cancer: how to make them better?
    Andrews DM, Maraskovsky E, Smyth MJ.
    Immunol Rev; 2008 Apr 04; 222():242-55. PubMed ID: 18364006
    [Abstract] [Full Text] [Related]

  • 37. Active specific immunotherapy phase III trials for malignant melanoma: systematic analysis and critical appraisal.
    Rosenthal R, Viehl CT, Guller U, Weber WP, Adamina M, Spagnoli GC, Heberer M, Zuber M.
    J Am Coll Surg; 2008 Jul 04; 207(1):95-105. PubMed ID: 18589368
    [No Abstract] [Full Text] [Related]

  • 38. Mutual helper effect in copulsing of dendritic cells with 2 antigens: a novel approach for improvement of dendritic-based vaccine efficacy against tumors and infectious diseases simultaneously.
    Shojaeian J, Jeddi-Tehrani M, Dokouhaki P, Mahmoudi AR, Ghods R, Bozorgmehr M, Nikoo S, Bayat AA, Akhondi MM, Ostadkarampour M, Rezania S, Zarnani AH.
    J Immunother; 2009 May 04; 32(4):325-32. PubMed ID: 19342973
    [Abstract] [Full Text] [Related]

  • 39. Immunotherapy against angiogenesis-associated targets: evidence and implications for the treatment of malignant glioma.
    Everson RG, Graner MW, Gromeier M, Vredenburgh JJ, Desjardins A, Reardon DA, Friedman HS, Friedman AH, Bigner DD, Sampson JH.
    Expert Rev Anticancer Ther; 2008 May 04; 8(5):717-32. PubMed ID: 18471045
    [Abstract] [Full Text] [Related]

  • 40. Vaccines for the treatment of non-small cell lung cancer: a renewed anticancer strategy.
    Gridelli C, Rossi A, Maione P, Ferrara ML, Castaldo V, Sacco PC.
    Oncologist; 2009 Sep 04; 14(9):909-20. PubMed ID: 19726457
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.